Congratulations to Faraneh on Completing Lab2Market Validate!

Faraneh Falah has completed Lab2Market Validate, and we could not be prouder. everMedi grew out of hard, honest questions about medication in real life — the kind of work this program is built to back.

On April 22, 2026, at the University of Calgary, she gave her final pitch to her cohort. The spotlight moment was only the visible edge of the story: months of showing up, revising, and learning in public — the sort of growth you only get when you are not allowed to stay in a tidy, hypothetical world.

Lab2Market is not about perfect slides in a quiet room. It is about whether your idea can stand up in the world. For Faraneh, that has meant going to where people already are — in worry, in routine, in the middle of incomplete information — and coming back to the work even when the stories were hard to sit with. Dr. Sara Saeedi has been there through all of it: supervising, nudging, and standing behind the project. We are grateful for that.

What the work looked like

Faraneh’s work started with listening before building. L2M pushed her to swap easy stories for what she actually heard. In her own words, that began like this:

L2M asked me to stop assuming and start listening. So that’s what I did. I reached out to caregivers, patients, pharmacists, nurses, social workers, and family physicians all across Alberta — fifty conversations in total.

Some of those conversations were light; others were heavy, and they stayed with her. She reflects:

Some of them were heavy. I remember sitting with a family caregiver who told me she hadn’t slept properly in months — too afraid that her mother might take the wrong dose while she wasn’t there. That kind of thing doesn’t leave you. Neither does hearing a pharmacist say, “we do everything right here, but once they walk out the door, we have no idea what happens next.”

From there, the problem she thought she was solving began to change shape:

I came into this thinking the problem was about reminders. I was wrong. What people actually needed was confirmation — the certainty that a dose had been taken, not just the hope that it had. Patients weren’t simply forgetting; they were quietly underreporting. Caregivers weren’t just worried; they were operating completely in the dark. And care teams weren’t just out of the loop — they had no loop at all once a prescription left the pharmacy.

The hardest part, she found, was holding both the emotional weight and the rigor the work required:

Holding that emotional weight while staying analytically rigorous — that was the real challenge of L2M. Some days I was a researcher. Some days I was just a person listening to another person’s pain. But I think that’s the point. The program teaches you to stay human while you build something that can scale.

By the time those conversations added up, a sharper picture of the need had emerged. Faraneh sums it up this way:

By the end of fifty conversations, three things were undeniable. Patients miss or double-dose because of memory loss. Caregivers have no reliable way to know whether a dose was taken. And medical staff lose all visibility the moment a patient walks out the door.

The tools to fix that don’t exist yet. So we set out to build them.

How we read that story

We hear the same through-line. People can need support beyond a nudge; families often need a reliable signal, not a guess. The care path can go dark once a prescription is back in someone’s day-to-day. everMedi is Faraneh’s bet on the evidence from those interviews — a path she has taken with a lot of care and a lot of backbone.

Faraneh, you walked in with a question. You are leaving with the evidence, the clarity, and the will to act on it. The UbiSensing & AI Lab is cheering you on, and we will be here for the next part. This is just the beginning.